PT Sarana Meditama Metropolitan Tbk

Jakarta Stock Exchange SAME.JK

PT Sarana Meditama Metropolitan Tbk EBIT Margin for the year ending December 31, 2023: 5.80%

PT Sarana Meditama Metropolitan Tbk EBIT Margin is 5.80% for the year ending December 31, 2023, a 27.30% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

PT Sarana Meditama Metropolitan Tbk EBIT Margin for the year ending December 31, 2022 was 4.55%, a -70.59% change year over year.
PT Sarana Meditama Metropolitan Tbk EBIT Margin for the year ending December 31, 2021 was 15.48%, a 341.39% change year over year.
PT Sarana Meditama Metropolitan Tbk EBIT Margin for the year ending December 31, 2020 was -6.41%, a -20.62% change year over year.
PT Sarana Meditama Metropolitan Tbk EBIT Margin for the year ending December 31, 2019 was -5.32%, a -131.50% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

Jakarta Stock Exchange: SAME.JK

PT Sarana Meditama Metropolitan Tbk

CEO	Mr. Jusup Halimi
IPO Date	Jan. 25, 2013
Location	Indonesia
Headquarters	Jalan Pulomas Barat VI No. 20
Employees	2,761
Sector	Health Care
Industries Hospitals & Clinics Pharmaceuticals

Description

PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.

Key trends

Past 5 years